Skip to main content
PMC home page
Gut logoLink to Gut
. 1989 Sep;30(9):1165–1172. doi: 10.1136/gut.30.9.1165

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

L J O'Donnell 1, M J Farthing 1
PMCID: PMC1434261  PMID: 2680792

Full text

PDF
1165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Sato H., Dupont A., Nishi N., Schally A. V. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science. 1975 Sep 19;189(4207):1007–1009. doi: 10.1126/science.56779. [DOI] [PubMed] [Google Scholar]
  2. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982 Sep 13;31(11):1133–1140. doi: 10.1016/0024-3205(82)90087-x. [DOI] [PubMed] [Google Scholar]
  3. Baxter J. N., Jenkins S. A., Day D. W., Roberts N. B., Cowell D. C., Mackie C. R., Shields R. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg. 1985 May;72(5):382–385. doi: 10.1002/bjs.1800720516. [DOI] [PubMed] [Google Scholar]
  4. Bloom S. R., Ralphs D. N., Besser G. M., Hall R., Coy D. H., Kastin A. J., Schally A. V. Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut. 1975 Oct;16(10):834–834. [PubMed] [Google Scholar]
  5. Bordas J. M., Toledo V., Mondelo F., Rodés J. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res. 1988;29(2-3):106–108. doi: 10.1159/000180981. [DOI] [PubMed] [Google Scholar]
  6. Bosch J., Kravetz D., Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981 Mar;80(3):518–525. [PubMed] [Google Scholar]
  7. Bosch J., Mastai R., Kravetz D., Bruix J., Rigau J., Rodés J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol. 1985;1(2):125–139. doi: 10.1016/s0168-8278(85)80761-3. [DOI] [PubMed] [Google Scholar]
  8. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  9. Buck M., Kvols L. K., O'Dorisio T. M. Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma. Am J Med. 1987 May 29;82(5B):92–95. doi: 10.1016/0002-9343(87)90433-5. [DOI] [PubMed] [Google Scholar]
  10. Ch'ng J. L., Anderson J. V., Williams S. J., Carr D. H., Bloom S. R. Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue. Br Med J (Clin Res Ed) 1986 Apr 12;292(6526):981–982. doi: 10.1136/bmj.292.6526.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ch'ng J. L., Anderson J. V., Williams S. J., Carr D. H., Bloom S. R. Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue. Br Med J (Clin Res Ed) 1986 Apr 12;292(6526):981–982. doi: 10.1136/bmj.292.6526.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Choi T. K., Mok F., Zhan W. H., Fan S. T., Lai E. C., Wong J. Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut. 1989 Feb;30(2):223–227. doi: 10.1136/gut.30.2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Clements D., Elias E. Regression of metastatic vipoma with somatostatin analogue SMS 201-995. Lancet. 1985 Apr 13;1(8433):874–875. doi: 10.1016/s0140-6736(85)92235-4. [DOI] [PubMed] [Google Scholar]
  14. Clements D., Rhodes J. M., Elias E. Effect of somatostatin on oesophageal variceal pressure assessed by direct measurement. J Hepatol. 1986;2(2):262–266. doi: 10.1016/s0168-8278(86)80085-x. [DOI] [PubMed] [Google Scholar]
  15. Coraggio F., Scarpato P., Spina M., Lombardi S. Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. Br Med J (Clin Res Ed) 1984 Jul 28;289(6439):224–224. doi: 10.1136/bmj.289.6439.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dollinger H. C., Raptis S., Pfeiffer E. F. Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res. 1976 Jan;8(1):74–78. doi: 10.1055/s-0028-1093677. [DOI] [PubMed] [Google Scholar]
  17. Ellison E. C., O'Dorisio T. M., Benson G. D. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin. Am J Surg. 1986 Jun;151(6):668–675. doi: 10.1016/0002-9610(86)90038-3. [DOI] [PubMed] [Google Scholar]
  18. Eriksson L. S., Law D. H., Sato Y., Wahren J. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis. Clin Physiol. 1984 Feb;4(1):5–11. doi: 10.1111/j.1475-097x.1984.tb00639.x. [DOI] [PubMed] [Google Scholar]
  19. Evensen D., Hanssen K. F., Berstad A. The effect on intestinal calcium absorption of somatostatin in man. Scand J Gastroenterol. 1978;13(4):449–451. doi: 10.3109/00365527809181920. [DOI] [PubMed] [Google Scholar]
  20. Fuessl H. S., Carolan G., Williams G., Bloom S. R. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion. 1987;36(2):101–107. doi: 10.1159/000199407. [DOI] [PubMed] [Google Scholar]
  21. Geerdsen J. P., Pedersen V. M., Kjaergård H. K. Small bowel fistulas treated with somatostatin: preliminary results. Surgery. 1986 Nov;100(5):811–814. [PubMed] [Google Scholar]
  22. Genazzani A. R., Petraglia F., Sinforiani E., Brambilla F., Facchinetti F., Nappi G. Dysregulation of plasma pro-opiomelanocortin-related peptides in neurotic depression. Acta Endocrinol (Copenh) 1986 May;112(1):1–6. doi: 10.1530/acta.0.1120001. [DOI] [PubMed] [Google Scholar]
  23. Goldberg D. J., Walesky M., Sherwin R. S. Effect of somatostatin on the plasma amino acid response to ingested protein in man. Metabolism. 1979 Aug;28(8):866–873. doi: 10.1016/0026-0495(79)90214-2. [DOI] [PubMed] [Google Scholar]
  24. Heij H. A., Bruining H. A., Verschoor L. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula. Pancreas. 1986;1(2):188–190. doi: 10.1097/00006676-198603000-00014. [DOI] [PubMed] [Google Scholar]
  25. Hild P., Dobroschke J., Henneking K., Rieck B. Treatment of enterocutaneous fistulas with somatostatin. Lancet. 1986 Sep 13;2(8507):626–626. doi: 10.1016/s0140-6736(86)92445-1. [DOI] [PubMed] [Google Scholar]
  26. Hopman W. P., Wolberink R. G., Lamers C. B., Van Tongeren J. H. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg. 1988 Feb;207(2):155–159. doi: 10.1097/00000658-198802000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jenkins S. A., Baxter J. N., Corbett W. A., Shields R. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man. Br J Surg. 1985 Dec;72(12):1009–1012. doi: 10.1002/bjs.1800721225. [DOI] [PubMed] [Google Scholar]
  28. Jenkins S. A., Baxter J. N., Corbett W., Devitt P., Ware J., Shields R. A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):275–278. doi: 10.1136/bmj.290.6464.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kayasseh L., Gyr K., Keller U., Stalder G. A., Wall M. Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial. Lancet. 1980 Apr 19;1(8173):844–846. doi: 10.1016/s0140-6736(80)91352-5. [DOI] [PubMed] [Google Scholar]
  30. Kingsnorth A. N., Moss J. G., Small W. P. Failure of somatostatin to accelerate closure of enterocutaneous fistulas in patients receiving total parenteral nutrition. Lancet. 1986 May 31;1(8492):1271–1271. doi: 10.1016/s0140-6736(86)91406-6. [DOI] [PubMed] [Google Scholar]
  31. Kleber G., Sauerbruch T., Fischer G., Paumgartner G. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut. 1988 Feb;29(2):153–156. doi: 10.1136/gut.29.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Koelz A., Kraenzlin M., Gyr K., Meier V., Bloom S. R., Heitz P., Stalder H. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma. Gastroenterology. 1987 Feb;92(2):527–531. doi: 10.1016/0016-5085(87)90153-3. [DOI] [PubMed] [Google Scholar]
  33. Kravetz D., Bosch J., Terés J., Bruix J., Rimola A., Rodés J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology. 1984 May-Jun;4(3):442–446. doi: 10.1002/hep.1840040315. [DOI] [PubMed] [Google Scholar]
  34. Krulich L., Dhariwal A. P., McCann S. M. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968 Oct;83(4):783–790. doi: 10.1210/endo-83-4-783. [DOI] [PubMed] [Google Scholar]
  35. Kvols L. K., Buck M., Moertel C. G., Schutt A. J., Rubin J., O'Connell M. J., Hahn R. G. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med. 1987 Aug;107(2):162–168. doi: 10.7326/0003-4819-107-2-162. [DOI] [PubMed] [Google Scholar]
  36. Kvols L. K., Buck M., Moertel C. G., Schutt A. J., Rubin J., O'Connell M. J., Hahn R. G. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med. 1987 Aug;107(2):162–168. doi: 10.7326/0003-4819-107-2-162. [DOI] [PubMed] [Google Scholar]
  37. Kvols L. K., Martin J. K., Marsh H. M., Moertel C. G. Rapid reversal of carcinoid crisis with a somatostatin analogue. N Engl J Med. 1985 Nov 7;313(19):1229–1230. doi: 10.1056/NEJM198511073131915. [DOI] [PubMed] [Google Scholar]
  38. Kvols L. K., Moertel C. G., O'Connell M. J., Schutt A. J., Rubin J., Hahn R. G. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986 Sep 11;315(11):663–666. doi: 10.1056/NEJM198609113151102. [DOI] [PubMed] [Google Scholar]
  39. Limberg B., Kommerell B. Treatment of acute pancreatitis with somatostatin. N Engl J Med. 1980 Jul 31;303(5):284–284. doi: 10.1056/NEJM198007313030517. [DOI] [PubMed] [Google Scholar]
  40. Long R. G., Adrian T. E., Bloom S. R. Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) 1985 Mar 23;290(6472):886–888. doi: 10.1136/bmj.290.6472.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Longnecker S. M. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide. Drug Intell Clin Pharm. 1988 Feb;22(2):136–138. doi: 10.1177/106002808802200207. [DOI] [PubMed] [Google Scholar]
  42. Magnusson I., Ihre T., Johansson C., Seligson U., Törngren S., Uvnäs-Moberg K. Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut. 1985 Mar;26(3):221–226. doi: 10.1136/gut.26.3.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mogard M. H., Maxwell V., Wong H., Reedy T. J., Sytnik B., Walsh J. H. Somatostatin may not be a hormonal messenger of fat-induced inhibition of gastric functions. Gastroenterology. 1988 Feb;94(2):405–408. doi: 10.1016/0016-5085(88)90429-5. [DOI] [PubMed] [Google Scholar]
  44. Myrèn C. J., Wara P., Christensen J. B. Somatostatin in the treatment of persisting pancreatic fistula--a report of two cases. Ann Chir Gynaecol. 1986;75(5):295–297. [PubMed] [Google Scholar]
  45. Nubiola-Calonge P., Badía J. M., Sancho J., Gil M. J., Segura M., Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet. 1987 Sep 19;2(8560):672–674. doi: 10.1016/s0140-6736(87)92452-4. [DOI] [PubMed] [Google Scholar]
  46. Price B. A., Jaffe B. M., Zinner M. J. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog. Gastroenterology. 1985 Jan;88(1 Pt 1):80–85. doi: 10.1016/s0016-5085(85)80136-0. [DOI] [PubMed] [Google Scholar]
  47. Prinz R. A., Pickleman J., Hoffman J. P. Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg. 1988 Jan;155(1):36–42. doi: 10.1016/s0002-9610(88)80255-1. [DOI] [PubMed] [Google Scholar]
  48. Reasbeck P. G., Van Rij A. M. The effect of somatostatin on dumping after gastric surgery: a preliminary report. Surgery. 1986 Apr;99(4):462–468. [PubMed] [Google Scholar]
  49. Redding T. W., Schally A. V. Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1078–1082. doi: 10.1073/pnas.80.4.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Reubi J. C. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol (Copenh) 1985 May;109(1):108–114. doi: 10.1530/acta.0.1090108. [DOI] [PubMed] [Google Scholar]
  51. Rodrigues C. A., Lennard-Jones J. E., Thompson D. G., Farthing M. J. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther. 1989 Apr;3(2):159–169. doi: 10.1111/j.1365-2036.1989.tb00202.x. [DOI] [PubMed] [Google Scholar]
  52. Schwedes U., Althoff P. H., Klempa I., Leuschner U., Mothes L., Raptis S., Wdowinski J., Usadel K. H. Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res. 1979 Dec;11(12):655–661. doi: 10.1055/s-0028-1092793. [DOI] [PubMed] [Google Scholar]
  53. Somerville K. W., Henry D. A., Davies J. G., Hine K. R., Hawkey C. J., Langman M. J. Somatostatin in treatment of haematemesis and melaena. Lancet. 1985 Jan 19;1(8421):130–132. doi: 10.1016/s0140-6736(85)91903-8. [DOI] [PubMed] [Google Scholar]
  54. Sonnenberg A., West C. Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut. 1983 Feb;24(2):148–153. doi: 10.1136/gut.24.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Svensson J. O., Gelin J., Svanvik J. Gallstones, cholecystectomy, and duodenogastric reflux of bile acid. Scand J Gastroenterol. 1986 Mar;21(2):181–187. doi: 10.3109/00365528609034644. [DOI] [PubMed] [Google Scholar]
  56. Talley N. J., Turner I., Middleton W. R. Somatostatin and symptomatic relief of irritable bowel syndrome. Lancet. 1987 Nov 14;2(8568):1144–1144. doi: 10.1016/s0140-6736(87)91564-9. [DOI] [PubMed] [Google Scholar]
  57. Tamás G., Jr, Tulassay Z., Papp J., Paksy A., Korányi L., Kisfaludy S., Kollin E., Steczek K. Effect of somatostatin on the pancreatitis-like biochemical changes due to endoscopic pancreatography: preliminary report. Metabolism. 1978 Sep;27(9 Suppl 1):1333–1336. doi: 10.1016/0026-0495(78)90068-9. [DOI] [PubMed] [Google Scholar]
  58. Tulassay Z., Tulassay T., Tamas G., Jr Benefit of somatostatin in dumping syndrome. Surgery. 1988 Jan;103(1):130–131. [PubMed] [Google Scholar]
  59. Wahren J. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet. 1976 Dec 4;2(7997):1213–1216. doi: 10.1016/s0140-6736(76)91142-9. [DOI] [PubMed] [Google Scholar]
  60. Williams N. S., Cooper J. C., Axon A. T., King R. F., Barker M. Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J (Clin Res Ed) 1984 Oct 20;289(6451):1027–1028. doi: 10.1136/bmj.289.6451.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. di Costanzo J., Cano N., Martin J., Richieri J. P., Mercier R., Lafille C., Lepeuch D. Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin. JPEN J Parenter Enteral Nutr. 1987 Sep-Oct;11(5):465–470. doi: 10.1177/0148607187011005465. [DOI] [PubMed] [Google Scholar]
  62. di Costanzo J., Cano N., Martin J. Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition. Lancet. 1982 Aug 7;2(8293):338–339. doi: 10.1016/s0140-6736(82)90314-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES